Home | Technology News Search Engine:
|
|
|
Home: Technology News:
|
|
(IT-NEWSWIRE.COM, June 25, 2018 ) Global IVD Market was valued at USD 62.01 Billion in the year 2017. Global IVD market is further estimated to grow at a CAGR of 6.61% from 2018 to reach USD 91.04 Billion.
North America region holds the highest market share in 2016 while APAC region is considered as the fastest growing market in the forecasted period. At country level, U.S is the biggest market in 2016 and it is projected to grow at a gradual pace in the coming years.
Grifols (Spain), Roche Diagnostics (Switzerland), bioMérieux (France), Abbott Laboratories (U.S.) are some of the key players in the Global IVD market with Roche Diagnostics holding the highest market share. Better global reach, both at production and at an operational level is the main reason for holding this highest market share. Growing research and development expenditures to address changing demand of consumers, new product launches in recent years are some of the key market drivers. Organic growth strategies adopted by most of the top manufacturers in recent years is also provides comprehensive market opportunities for various stakeholder.
Request for Discount at https://www.prominentmarketresearch.com/discount-report/34267
Drivers Growing awareness of self-care medicines Growing infectious disease market and adoption of point-of-care testing Restrain Lack of regulatory standards Rising cost for better healthcare Opportunity Increasing significance of diagnostics in improving healthcare quality Growing R&D investments. Challenge Intense competition and declining healthcare reimbursement
The report is segmented as, by type, by technology, by end users and by region. The reagents and kits segment by type is likely to hold the largest market share during the forecast period. The growth can be attributed to the increasing number of blood donations, rising incidence of infectious diseases, and increasing capacity (disposable income) with wide range of available reagents and kits. On the other hand, hospitals by users is expected to grow at the highest CAGR during year 2017-2023 as increasing number of diagnostics tests carried out in hospitals.
Key Benefits for Stakeholders IVD product and OEM Manufacturers, manufacturers & Distributors Pathologists and Pathology Laboratories Research and Consulting organization Hospitals, Clinics and Healthcare Institutions
Request for Sample Report at https://www.prominentmarketresearch.com/sample-report/34267
By type Introduction Instruments Software and Services Reagents & Kits
By Technique Immunodiagnostics Blood testing Molecular diagnostics Tissue diagnostics Clinical chemistry Other IVD techniques
By Users Hospitals Point Of Care Testing Academic and Medical Schools Others
By Region North America Europe Asia-Pacific RoW
Key Players Abbott laboratories (U.S.) Beckman Coulter Inc. (U.S.) Biomérieux SA (France) Grifols SA (Spain) F. Hoffmann-La Roche AG (U.S.) Becton, Dickinson and Company (U.S.) Qiagen Netherlands (includes Digene) (Netherlands) Danaher Corporation (Beckman Coulter) Lab 21 (US) Siemens AG (Germany) Johnson & Johnson (U.S.)
Purchase Report Now at https://www.prominentmarketresearch.com/checkout/34267
About Prominent Market Research:
At Prominent Market Research, we are committed to provide the best possible service and recommendations to all our customers. You will be able to speak to seasoned analyst who will understand your research needs accurately. We make it our business to look after yours, with an efficient and friendly team always available to help you.
Prominent Market Research
Robin
+1-815-957-4373
sales@prominentmarketresearch.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|
Technology News Headlines
|
|
|
Technology Business Video Feed
|
More Technology Video Feeds
|
|
|